Agfa's Open Letter to De Tijd, Mediafin and De Persgroep

Agfa HealthCareDear Sir, I noted that De Tijd, and Bert Broens in particular, is continuing without abatement its 'damage Agfa-Gevaert' campaign. In recent months, we have noticed that this journalist continuously reports on Agfa-Gevaert in a one-sided negative manner and that he doesn't hesitate to publish inaccurate information.

The most striking examples were the articles published just before the General Meeting of Shareholders held in April. In these articles, he claimed that a number of important Agfa-Gevaert shareholders would vote against certain agenda items. When we checked this with our shareholders, the information turned out to be completely false. Templeton, our main shareholder, even felt forced to issue a press release to deny the content of the articles. In this case it is clear that even the most elementary rules of objective journalism were not observed.

Another example is a series of articles with completely false information about a possible operation involving Agfa Graphics. Insiders in the business know that this campaign was inspired by the management of Punch. I leave it to you to decide if this is ethically acceptable.

More recently, the campaign is aimed at Agfa HealthCare. This business group's important successes, such as the huge contract signed with the Paris hospitals, were minimized. In today's article some details were used to create a completely negative image.

It is obvious that we are not able to win every single contract. If that would be the case, we would hold a monopoly. Furthermore, it is only normal that occasionally a colleague leaves the company. It seems to me that this shouldn't be a reason for this type of negative coverage either.

Regarding this article, not a single contact was made with our company in order to at least check the accuracy of the information or to obtain additional information.

Again, I leave it to you to judge the quality of this kind of journalism.

I personally have put all means of communication at Bert Broens' disposal, my private mobile phone number included. I believe I can't do more than that.

Agfa-Gevaert is one of the few Belgian companies with very important global market shares in almost all of its activities. This goes for both our graphic and our healthcare business. Our competitors are therefore only too anxious to translate and spread this kind of articles amongst our customers.

Why a newspaper, which is presenting itself as the newspaper for the entrepreneurs in Flanders, is leading such a damaging campaign, goes beyond my comprehension.

It will therefore come to you as no surprise that I will demand - as a right to reply - the publication of a text from my hand, of comparable length in De Tijd.

In my opinion, this is the strict minimum that can be done to somewhat limit the significant economic damage created by this campaign.

Jo Cornu
CEO Agfa-Gevaert

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging and information technology companies. Agfa develops, manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), the healthcare sector (Agfa HealthCare) and specific industrial applications (Agfa Materials). Agfa's headquarters are in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries throughout the world. The Agfa-Gevaert Group achieved a turnover of 3,283 million Euro in 2007.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales. For more information on Agfa HealthCare, please visit www.agfa.com/healthcare.

Most Popular Now

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Forging a Novel Therapeutic Path for Pat…

Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are born with it and much fewer boys. It is caused by...

Integrating Care Records is Good. Using …

Opinion Article by Dr Paul Deffley, Chief Medical Officer, Alcidion. A single patient record already exists in the NHS. Or at least, that’s a perception shared by many. A survey of...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...